IDENTIFICATION OF FACTOR-XIIIA-REACTIVE GLUTAMINYL RESIDUES IN THE PROPOLYPEPTIDE OF BOVINE VON-WILLEBRAND-FACTOR

被引:16
作者
TAKAGI, J
AOYAMA, T
UEKI, S
OHBA, H
SAITO, Y
LORAND, L
机构
[1] TOKYO INST TECHNOL, FAC BIOSCI & BIOTECHNOL, DEPT BIOL SCI, MIDORI KU, YOKOHAMA, KANAGAWA 226, JAPAN
[2] NORTHWESTERN UNIV, SCH MED, DEPT CELL & MOLEC BIOL, CHICAGO, IL USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1995年 / 232卷 / 03期
关键词
VON WILLEBRAND FACTOR; PROPOLYPEPTIDE; FACTOR XIIIA; TRANSGLUTAMINASE; DANSYLCADAVERINE;
D O I
10.1111/j.1432-1033.1995.tb20872.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
von Willebrand factor is a large multimeric plasma protein which plays important roles in platelet aggregation, blood coagulation and probably also in the adhesion of endothelial cells. A 100-kDa propeptide, called the propolypeptide of von Willebrand factor (pp-vWF), is generated during biosynthesis. We found that pp-vWF served as a substrate for transglutaminases including human factor XIIIa and guinea pig liver transglutaminase [Usui, T., Takagi, J. & Saito, Y. (1993) J. Biol. Chem. 268, 12311-12316]. As such, it could form cross-linked copolymers with the extracellular matrix protein, laminin, making it all the more likely that pp-vWF plays a role in cell adhesion phenomena [Takagi, J., Sudo, Y., Saito, T. & Saito, Y. (1994) Eur. J. Biochem. 222, 861-867]. In this work, we identified the Gln residues in pp-vWF specifically reacting with blood coagulation factor XIIIa as amine accepters. The fluorescent amine, dansylcadaverine, was employed for labeling the enzyme-reactive sites of the protein. Following partial proteolysis, fragments containing the labeled Gin residues were isolated by passage through an anti-dansyl affinity chromatographic column. Amino acid sequence analyses of the fragments revealed that, out of about 40 Gln residues in pp-vWF, only four could be modified in the factor-XIIIa-catalyzed reaction.
引用
收藏
页码:773 / 777
页数:5
相关论文
共 50 条
  • [21] PLASMA VON-WILLEBRAND-FACTOR AND FIBRINOGEN VARIATIONS IN ISCHEMIC-HEART-DISEASE
    WIESEL, ML
    MOSSARD, JM
    GRUNEBAUM, L
    CAZENAVE, JP
    SACREZ, A
    ANNALES DE BIOLOGIE CLINIQUE, 1992, 50 (01) : 15 - 19
  • [22] ACQUIRED VON-WILLEBRAND DISEASE-ASSOCIATED WITH MULTIPLE-MYELOMA - CHARACTERIZATION OF AN INHIBITOR TO VON-WILLEBRAND-FACTOR
    MOHRI, H
    TANABE, J
    OHTSUKA, M
    YOSHIDA, M
    MOTOMURA, S
    NISHIDA, S
    FUJIMURA, Y
    OKUBO, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) : 561 - 566
  • [23] STRUCTURAL-ANALYSIS OF RECOMBINANT VON-WILLEBRAND-FACTOR - IDENTIFICATION OF HETERO-DIMERS AND HOMO-DIMERS
    FISCHER, B
    MITTERER, A
    SCHLOKAT, U
    DENBOUWMEESTER, R
    DORNER, F
    FEBS LETTERS, 1994, 351 (03) : 345 - 348
  • [24] VON-WILLEBRANDS DISEASE - LABORATORY INVESTIGATION USING AN IMPROVED FUNCTIONAL ASSAY FOR VON-WILLEBRAND-FACTOR
    FAVALORO, EJ
    GRISPO, L
    DINALE, A
    BERNDT, M
    KOUTTS, J
    PATHOLOGY, 1993, 25 (02) : 152 - 158
  • [25] CHARACTERIZATION OF 2 CASES OF ACQUIRED TRANSITORY VON-WILLEBRAND SYNDROME WITH CIPROFLOXACIN - EVIDENCE FOR HEIGHTENED PROTEOLYSIS OF VON-WILLEBRAND-FACTOR
    CASTAMAN, G
    LATTUADA, A
    MANNUCCI, PM
    RODEGHIERO, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (01) : 83 - 86
  • [26] ABSENCE OF INCORPORATION OF PLASMA VON-WILLEBRAND-FACTOR INTO PORCINE PLATELET ALPHA-GRANULES
    ROUSSI, J
    DROUET, L
    SIGMAN, J
    VAIMAN, M
    PIGNAUD, G
    BONNEAU, M
    MASSE, JM
    CRAMER, EM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) : 661 - 668
  • [27] RELEASE OF VON-WILLEBRAND-FACTOR BY CARDIOPULMONARY BYPASS, BUT NOT BY CARDIOPLEGIA IN OPEN-HEART-SURGERY
    VALEN, G
    BLOMBACK, M
    SELLEI, P
    LINDBLOM, D
    VAAGE, J
    THROMBOSIS RESEARCH, 1994, 73 (01) : 21 - 29
  • [28] VON-WILLEBRAND-FACTOR AND FIBRINOLYTIC VARIABLES ARE DIFFERENTLY AFFECTED IN THE INSULIN-RESISTANCE SYNDROME
    NILSSON, TK
    BOMAN, K
    BJERLE, P
    HALLMANS, G
    HELLSTEN, G
    JOURNAL OF INTERNAL MEDICINE, 1994, 235 (05) : 419 - 423
  • [29] DDAVPS SHORTENING OF THE BLEEDING-TIME SEEMS DUE TO PLASMA VON-WILLEBRAND-FACTOR
    BECK, KH
    BLECKMANN, U
    MOHR, P
    KRETSCHMER, V
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1995, 21 : 40 - 43
  • [30] Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects - Direct comparison of commercial ELISA-based von Willebrand factor activity options
    Favaloro, EJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 608 - 618